BIOMAT Database Logo BIOMAT Database Logo

Postnatal decline of maternally acquired antibodies in the rat. 1976

M J Cloonan, and G M Shortland

The decline (half-life) of maternally acquired antibodies of two different specificities (diphtheria and tetanus) was studied in rats. Essentially similar half-lives for antibody of each specificity were found in young rats from the same litter. In contrast, half-lives varied from 2 to 10 days in individuals of different litters. Significant differences in half-lives were demonstrated in young rats possessing markedly different initial titres of antibodies of the two specificities. It was established that there was a relationship between the half-life and the initial titre of antibody of each specificity which could be described by a rectangular hyperbola. These findings are in close aggreement with previous studies in human infants.

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004165 Diphtheria A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. Corynebacterium diphtheriae Infection,Corynebacterium diphtheriae Infections,Infection, Corynebacterium diphtheriae
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

M J Cloonan, and G M Shortland
Postnatal decline of maternally acquired rubella antibodies.
September 1970, The Journal of hygiene,
M J Cloonan, and G M Shortland
Postnatal decline of maternally acquired viral antibodies of different specificities.
September 1971, The Journal of hygiene,
M J Cloonan, and G M Shortland
[Measles & rubella hemagglutination inhibition antibodies in women of child-bearing age and the time of decline of maternally acquired antibodies among neonates and infants].
February 1985, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
M J Cloonan, and G M Shortland
Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
November 2018, Cell host & microbe,
M J Cloonan, and G M Shortland
Do maternally acquired antibodies protect infants from malaria infection?
February 2001, Parasite immunology,
M J Cloonan, and G M Shortland
Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children.
July 2000, The Pediatric infectious disease journal,
M J Cloonan, and G M Shortland
Maternally acquired runt disease.
January 1973, Science (New York, N.Y.),
M J Cloonan, and G M Shortland
Maternally and naturally acquired antibodies to Mannheimia haemolytica and Pasteurella multocida in beef calves.
June 2006, Veterinary immunology and immunopathology,
M J Cloonan, and G M Shortland
The temporary postnatal decline in glucuronidation of certain phenols by rat liver.
August 1983, The Biochemical journal,
M J Cloonan, and G M Shortland
First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies.
April 2014, PLoS pathogens,
Copied contents to your clipboard!